Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.360.360.340.340.70

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.36 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34
Mar20200.70

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34
-51.43
Mar2020 0.7 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses